WallStSmart

Salesforce.com Inc (CRM)vsDiebold Nixdorf, Incorporated (DBD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Salesforce.com Inc generates 977% more annual revenue ($41.52B vs $3.86B). CRM leads profitability with a 18.0% profit margin vs 2.8%. CRM trades at a lower P/E of 21.3x. CRM earns a higher WallStSmart Score of 70/100 (B).

CRM

Strong Buy

70

out of 100

Grade: B

Growth: 6.7Profit: 7.5Value: 8.0Quality: 6.0
Piotroski: 5/9Altman Z: 1.50

DBD

Buy

56

out of 100

Grade: C

Growth: 7.0Profit: 5.5Value: 5.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CRMUndervalued (+75.0%)

Margin of Safety

+75.0%

Fair Value

$703.64

Current Price

$191.10

$512.54 discount

UndervaluedFair: $703.64Overvalued

Intrinsic value data unavailable for DBD.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CRM5 strengths · Avg: 8.8/10
Debt/EquityHealth
0.0810/10

Conservative balance sheet, low leverage

Market CapQuality
$135.67B9/10

Large-cap with strong market position

Return on EquityProfitability
23.4%9/10

Every $100 of equity generates 23 in profit

PEG RatioValuation
0.998/10

Growing faster than its price suggests

Free Cash FlowQuality
$6.56B8/10

Generating 6.6B in free cash flow

DBD2 strengths · Avg: 9.0/10
EPS GrowthGrowth
815.0%10/10

Earnings expanding 815.0% YoY

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

Areas to Watch

CRM1 concerns · Avg: 4.0/10
Altman Z-ScoreHealth
1.504/10

Distress zone — elevated risk

DBD2 concerns · Avg: 3.5/10
P/E RatioValuation
28.0x4/10

Moderate valuation

Profit MarginProfitability
2.8%3/10

2.8% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : CRM

The strongest argument for CRM centers on Debt/Equity, Market Cap, Return on Equity. Profitability is solid with margins at 18.0% and operating margin at 19.2%. Revenue growth of 12.1% demonstrates continued momentum.

Bull Case : DBD

The strongest argument for DBD centers on EPS Growth, Price/Book.

Bear Case : CRM

The primary concerns for CRM are Altman Z-Score.

Bear Case : DBD

The primary concerns for DBD are P/E Ratio, Profit Margin. Thin 2.8% margins leave little buffer for downturns.

Key Dynamics to Monitor

CRM profiles as a mature stock while DBD is a value play — different risk/reward profiles.

DBD carries more volatility with a beta of 1.15 — expect wider price swings.

CRM is growing revenue faster at 12.1% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CRM scores higher overall (70/100 vs 56/100), backed by strong 18.0% margins and 12.1% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Salesforce.com Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Salesforce.com, Inc. is an American cloud-based software company headquartered in San Francisco, California. It provides customer relationship management (CRM) service and also provides a complementary suite of enterprise applications focused on customer service, marketing automation, analytics, and application development.

Visit Website →

Diebold Nixdorf, Incorporated

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Diebold Nixdorf, Incorporated provides connected commerce solutions to financial institutions and retailers in Western Europe, Eastern Europe, Asia, the Middle East, Africa, the United States, Canada, Mexico and Latin America. The company is headquartered in North Canton, Ohio.

Want to dig deeper into these stocks?